Annual Congress Stockholm 2007

Saturday, 15.09.2007
Sunday, 16.09.2007
Monday, 17.09.2007
Tuesday, 18.09.2007
Wednesday, 19.09.2007

Citations should be made in the following way: Authors. Title. Eur Respir J 2007; 30: Suppl. 51, abstract number.

Material from 2007:

4066 Abstracts
635 Slide presentations
310 Webcasts
98 Handouts
1992 e-posters
310 Multimedia files

Material from 2007: Show

Clinical trial: new biological approaches to respiratory diseases

Symposium
Chairs: B. Balbi (Veruno, Italy), U. Specks (Rochester, United States of America)
Aims: This session is designed to illustrate the results of two recently performed clinical trials involving patients with idiopathic pulmonary fibrosis and with asthma. These trials share the innovative approach to the treatment of these disorders, namely the biological approach by means of a cytokine (gamma-interferon) for patients with idiopathic pulmonary fibrosis and an anti-cytokine antibody (anti-TNF-alpha) for asthma.

Download all media

A randomized, double-blind, placebo-controlled, phase III study of the safety and efficacy of interferon gamma-1b in patients with idiopathic pulmonary fibrosis T. King, Jr (San Francisco, United States of America)
Phase 2, mutlicenter, double-blind study of CNTO 148, a human monoclonal anti-TNF α antibody, in symptomatic patients with severe persistent asthma S. Wenzel (Pittsburgh, United States of America)